Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.14 [1.00-1.30],0.055681751393442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,Inverse variance weighted,10,1.07 [0.92-1.25],0.39512855627102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,Inverse variance weighted,13,1.03 [0.97-1.10],0.351716392226155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,Inverse variance weighted,35,1.04 [0.98-1.11],0.194227464078441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.99 [0.87-1.12],0.883861450016102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,24,0.95 [0.91-1.00],0.0483697774776871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,1.01 [0.95-1.06],0.804192065375934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,Inverse variance weighted,7,0.96 [0.83-1.11],0.582171147093131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.98 [0.88-1.10],0.748337390752519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,55,0.97 [0.95-0.99],0.0022496529711124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,1.05 [0.98-1.11],0.150568365647815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,10,0.96 [0.81-1.14],0.612724403046612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,54,0.99 [0.96-1.02],0.512665136639529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,0.99 [0.85-1.15],0.897887848769357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,59,1.02 [0.97-1.06],0.428558954633606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.04 [0.99-1.08],0.124553812016697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.02 [0.98-1.05],0.353775307106116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.96 [0.90-1.03],0.265287966067564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,Inverse variance weighted,49,1.01 [0.97-1.06],0.557762443311031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,13,0.95 [0.88-1.03],0.235560615869212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,1.02 [0.99-1.04],0.238327057697404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.93 [0.84-1.02],0.13151244587466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,Inverse variance weighted,64,0.98 [0.95-1.01],0.188023266276178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [0.81-1.35],0.732858156566383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,1.05 [0.93-1.19],0.416848950798625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,Inverse variance weighted,6,0.92 [0.83-1.03],0.161253696315309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.99 [0.96-1.02],0.457813397373568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.95 [0.87-1.05],0.342199539512809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,54,0.98 [0.92-1.06],0.661399241670767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,Inverse variance weighted,65,1.00 [0.98-1.03],0.750405709914357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,Inverse variance weighted,35,0.98 [0.94-1.01],0.23062211573393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,0.89 [0.75-1.05],0.153330734102841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,Inverse variance weighted,7,0.96 [0.83-1.11],0.57949621914515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,Inverse variance weighted,7,1.05 [0.97-1.14],0.225764085041849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.09 [0.94-1.26],0.239023171461583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,Inverse variance weighted,9,1.05 [0.97-1.14],0.238410915658897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.08 [0.97-1.20],0.147636719221772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,Inverse variance weighted,19,0.98 [0.89-1.07],0.633324292972417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,1.01 [0.95-1.07],0.784691780744128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,Inverse variance weighted,14,0.99 [0.89-1.10],0.797831536636534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,Inverse variance weighted,11,0.98 [0.92-1.06],0.684513508934716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.00 [0.94-1.05],0.864893564962426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,0.98 [0.92-1.03],0.396207839492163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.97 [0.86-1.10],0.655708579507554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,44,0.98 [0.96-1.01],0.278267992378917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,0.98 [0.90-1.08],0.72603676777921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.02 [0.97-1.08],0.499216407493214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,Inverse variance weighted,60,1.04 [1.00-1.07],0.0243910909409207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,1.02 [0.96-1.08],0.583220090699247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1.01 [0.95-1.07],0.839888569307455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,Inverse variance weighted,12,0.99 [0.90-1.10],0.895255586577899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,20,1.08 [1.00-1.16],0.0475659090470568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,22,1.02 [0.98-1.07],0.357924495444221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,Inverse variance weighted,13,1.01 [0.92-1.11],0.796764052769019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,Inverse variance weighted,12,0.98 [0.91-1.05],0.568911238459023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,1.00 [0.95-1.06],0.889739335973966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.15 [1.03-1.28],0.0117619504450032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,14,1.02 [0.96-1.09],0.510734625617433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.00 [0.88-1.14],0.974734614050831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,16,1.00 [0.89-1.12],0.99825600544263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,Inverse variance weighted,23,1.01 [0.96-1.07],0.635525544162004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,24,0.96 [0.91-1.02],0.172153890302614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,Inverse variance weighted,11,1.03 [0.94-1.13],0.496105952680677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,Inverse variance weighted,32,1.01 [0.97-1.04],0.691138833505612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.30 [0.91-1.86],0.145949993473531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.76 [0.58-0.99],0.0451512195169438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.12 [0.89-1.40],0.342344696387601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,23,0.96 [0.91-1.02],0.15152328804118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,Inverse variance weighted,38,0.98 [0.94-1.02],0.349104065013243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.99 [0.94-1.05],0.796603676728392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.96 [0.91-1.02],0.227455086960884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,0.96 [0.87-1.05],0.343481123067172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,Inverse variance weighted,12,1.05 [0.97-1.13],0.232639857561152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,49,1.01 [0.98-1.05],0.367808495250181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.03 [0.97-1.10],0.295015615374642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,Inverse variance weighted,37,1.01 [0.98-1.04],0.693911085952532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.96 [0.88-1.05],0.385482744877128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.07 [1.00-1.13],0.0380775595633288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.00 [0.97-1.03],0.925327399710475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,33,1.08 [1.02-1.14],0.0142382852210682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,Inverse variance weighted,13,1.09 [0.97-1.24],0.153677561400634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,Inverse variance weighted,16,1.02 [0.94-1.10],0.682353112678555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.03 [0.96-1.10],0.408154991654494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,Inverse variance weighted,7,0.89 [0.80-0.99],0.0353189262273704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.03 [0.98-1.09],0.257401043272179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.00 [0.97-1.04],0.974161309374817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,Inverse variance weighted,5,1.11 [0.95-1.29],0.184176745943425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,7,1.13 [0.91-1.41],0.278594771587418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,1.01 [0.97-1.05],0.717006117298683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,6,1.02 [0.86-1.21],0.838049567772743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.96 [0.80-1.15],0.67649180291123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,Inverse variance weighted,17,0.90 [0.84-0.97],0.0037860829324322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,1.00 [0.97-1.03],0.911057054226777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,0.97 [0.89-1.06],0.500709342353361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,1.00 [0.94-1.06],0.897859517893997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.97 [0.94-1.00],0.0470457414436589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,1.01 [0.57-1.78],0.974814623817987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.95 [0.85-1.06],0.38100906351649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,1.06 [0.96-1.17],0.255377837852675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,Inverse variance weighted,6,0.84 [0.73-0.97],0.0190682764751556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.01 [0.97-1.05],0.647121229917089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,Inverse variance weighted,20,0.96 [0.90-1.02],0.203336592588006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.00 [0.95-1.05],0.982329339821111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.93 [0.80-1.08],0.353538488696975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.06 [0.91-1.24],0.429560943500465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.34 [0.81-2.22],0.257976936206688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,6,0.97 [0.91-1.04],0.397479147873429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,Inverse variance weighted,8,1.00 [0.87-1.15],0.978532320235046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,1.08 [1.01-1.17],0.0360454448822396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,2,0.84 [0.66-1.07],0.165243993154649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,31,1.00 [0.93-1.07],0.967133139957425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.93-1.05],0.661196734375116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,Inverse variance weighted,17,1.02 [0.94-1.10],0.656118499998719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,Inverse variance weighted,37,0.99 [0.94-1.04],0.741216719737249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,Inverse variance weighted,50,1.03 [0.99-1.07],0.171715952824783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,Inverse variance weighted,3,0.80 [0.62-1.04],0.095538247570238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.95 [0.84-1.08],0.453818004835056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,0.99 [0.82-1.18],0.890018436094339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.99 [0.97-1.02],0.559488823324391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,Inverse variance weighted,21,1.01 [0.95-1.09],0.667662722362662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.99 [0.83-1.18],0.93582880369558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.04 [0.97-1.12],0.278960438052194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.93 [0.86-1.00],0.064422511331647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.88 [0.73-1.05],0.143559923989264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,66,0.99 [0.96-1.02],0.56480729429626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,0.97 [0.82-1.13],0.668484881751286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,4,1.01 [0.87-1.17],0.914173669049505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.01 [0.96-1.07],0.653712940305589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,Inverse variance weighted,15,1.00 [0.88-1.14],0.997694089577774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,Inverse variance weighted,17,1.00 [0.95-1.06],0.996208302959404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,28,1.04 [0.95-1.14],0.375007349443956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,Inverse variance weighted,5,1.18 [0.95-1.46],0.133646507744511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,19,1.01 [0.94-1.09],0.7150398102962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,27,0.98 [0.93-1.04],0.587280700167448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.02 [0.97-1.07],0.383901371316305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.97 [0.81-1.15],0.722179427018335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,25,1.00 [0.95-1.06],0.875916062305401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,Inverse variance weighted,23,0.98 [0.91-1.07],0.69318359378094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,Inverse variance weighted,9,1.00 [0.90-1.10],0.941371838552915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,83,1.00 [0.97-1.03],0.959311400087574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.02 [0.93-1.12],0.658491373861698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,Inverse variance weighted,11,0.93 [0.77-1.12],0.460518455752716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,47,1.01 [0.98-1.04],0.503889348527915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,8,1.00 [0.87-1.16],0.991462016066179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.99 [0.91-1.07],0.732288560246091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,Inverse variance weighted,9,1.12 [0.98-1.29],0.0985135588365072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.03 [1.00-1.07],0.0352596770325273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,0.68 [0.48-0.98],0.037475237849559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,0.97 [0.88-1.06],0.445983413311135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.02 [0.87-1.20],0.781779449481059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,Inverse variance weighted,34,1.02 [0.98-1.05],0.415061954026094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.09 [0.98-1.22],0.105008492679113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,1.07 [0.94-1.22],0.280597464464034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,Inverse variance weighted,46,0.99 [0.96-1.02],0.53452383301993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,Inverse variance weighted,9,0.98 [0.89-1.08],0.673445738486905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.92 [0.71-1.19],0.523807518105446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,Inverse variance weighted,23,0.98 [0.90-1.07],0.670443146484533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,Inverse variance weighted,16,0.98 [0.90-1.07],0.627036023508675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,Inverse variance weighted,3,1.18 [1.02-1.38],0.0284786757076141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,28,1.00 [0.94-1.06],0.944407493617036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,10,1.14 [0.91-1.42],0.244919920254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.94 [0.89-0.99],0.0182483704940807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,8,0.94 [0.81-1.10],0.432089453988074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.92-1.06],0.730037530196577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,35,0.99 [0.95-1.04],0.787251251692386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,Inverse variance weighted,17,1.04 [0.98-1.10],0.234163684336915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.00 [0.93-1.07],0.965785270010224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,Inverse variance weighted,40,1.01 [0.98-1.05],0.462107105079937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,Inverse variance weighted,10,1.00 [0.94-1.07],0.992701259022086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.95-1.06],0.846850506263463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,0.93 [0.88-0.97],0.0028152256986639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.14 [0.79-1.66],0.484770185409752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.03 [0.97-1.08],0.36381060465438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.03 [0.89-1.20],0.665204436757221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.00 [0.96-1.04],0.985946852527135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,36,1.04 [1.00-1.07],0.0338668722287791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.06 [0.90-1.25],0.483179312935792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,Inverse variance weighted,8,0.96 [0.83-1.12],0.605351653533787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,0.97 [0.91-1.03],0.324571945216115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,Inverse variance weighted,29,0.90 [0.84-0.97],0.0087195904705788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.85 [0.70-1.04],0.106413266307599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,0.90 [0.76-1.06],0.201613391483886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,Inverse variance weighted,30,0.99 [0.93-1.05],0.760387485239163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,Inverse variance weighted,7,1.04 [0.94-1.14],0.453708986460119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.09 [1.02-1.17],0.0121410278936293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,Inverse variance weighted,81,0.99 [0.96-1.02],0.40021797701139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,1.01 [0.98-1.04],0.441004142777948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.09 [0.97-1.23],0.157326804170442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,1.05 [0.97-1.14],0.259630115176335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,Inverse variance weighted,24,1.07 [0.99-1.17],0.0890207260083171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.83 [0.65-1.04],0.103157333917668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,Inverse variance weighted,4,1.01 [0.89-1.14],0.928068427156885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,1.03 [0.94-1.13],0.479809479635161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,Inverse variance weighted,6,0.95 [0.81-1.12],0.57801174971754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,Inverse variance weighted,25,1.03 [0.99-1.08],0.154110324387665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.01 [0.87-1.16],0.915608374327882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,Inverse variance weighted,19,1.08 [0.97-1.21],0.168509275973288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,Inverse variance weighted,15,0.96 [0.90-1.03],0.219835621502105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.08 [1.00-1.17],0.0467785551626566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,0.93 [0.83-1.03],0.143839608685624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,Inverse variance weighted,14,1.00 [0.91-1.10],0.963115571963576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.88-1.05],0.361225800772503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,Inverse variance weighted,26,1.04 [0.98-1.09],0.177529204161634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.87-1.18],0.885605725812421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,Inverse variance weighted,14,0.99 [0.90-1.08],0.786983650930407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,Inverse variance weighted,16,1.04 [0.98-1.10],0.152163567923113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.92 [0.54-1.56],0.751166917841027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,Inverse variance weighted,3,1.02 [0.93-1.12],0.648715103936031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,Inverse variance weighted,16,1.03 [0.89-1.19],0.721782733800352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,Inverse variance weighted,15,0.97 [0.88-1.07],0.484990003803395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,53,0.97 [0.94-1.00],0.0272970919423014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,37,0.99 [0.94-1.05],0.803450278210731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.08 [0.83-1.42],0.550499086535939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,Inverse variance weighted,53,1.05 [1.01-1.09],0.0082864755645566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,Inverse variance weighted,39,1.07 [1.03-1.12],0.0020543845284067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.03 [0.95-1.12],0.494429783345306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,11,0.95 [0.87-1.05],0.302350428915999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.06 [0.98-1.15],0.138999207335283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,Inverse variance weighted,33,0.98 [0.94-1.03],0.418866117090449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,4,0.94 [0.75-1.17],0.562851888461229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.98 [0.92-1.05],0.59043456737427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,32,1.02 [0.96-1.08],0.525347473857712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,6,0.99 [0.88-1.11],0.829107497926038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.05 [0.88-1.24],0.598822396669287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.03 [0.99-1.08],0.162084227506192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.01 [0.89-1.16],0.83418813074177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,Inverse variance weighted,21,0.97 [0.86-1.09],0.565299494498839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,Inverse variance weighted,5,0.94 [0.75-1.17],0.561876715949886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,32,0.98 [0.94-1.02],0.25420636402791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,Inverse variance weighted,30,0.98 [0.94-1.03],0.409960169527957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.08 [1.01-1.15],0.0240644873695274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,Inverse variance weighted,5,0.83 [0.69-1.00],0.0455565570254063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.95 [0.82-1.11],0.509069942680769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,Inverse variance weighted,19,1.08 [0.95-1.22],0.228153921080206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,0.97 [0.92-1.01],0.157413983323789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.95 [0.84-1.07],0.391416720772451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,Inverse variance weighted,25,1.04 [0.98-1.10],0.166903626546875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,Inverse variance weighted,16,0.90 [0.79-1.02],0.0924921256256053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.01 [0.98-1.05],0.477080677732679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.96 [0.89-1.04],0.319913252527759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,Inverse variance weighted,20,1.03 [0.97-1.10],0.288976205358098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,Inverse variance weighted,22,1.06 [0.98-1.15],0.148386744420934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.97 [0.92-1.03],0.329002416038457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,0.95 [0.86-1.05],0.303088611148711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,18,0.97 [0.90-1.05],0.41722269258086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.10 [0.87-1.40],0.413269674289196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,53,1.01 [0.98-1.03],0.663572041846552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,Inverse variance weighted,92,1.01 [0.99-1.03],0.449903718982061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,53,1.04 [1.00-1.09],0.0352557797875577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,0.94 [0.86-1.04],0.232817703692949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,Inverse variance weighted,42,1.00 [0.96-1.04],0.988219497000121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,1.00 [0.93-1.08],0.974259117924378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,Inverse variance weighted,8,1.21 [1.09-1.36],0.0005933022570486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,Inverse variance weighted,53,0.99 [0.96-1.02],0.406791240424824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.01 [0.95-1.08],0.684224760003254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,7,0.94 [0.82-1.06],0.294683170543032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,Inverse variance weighted,47,1.00 [0.96-1.05],0.842761226417703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.98 [0.92-1.04],0.506115757685411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,Inverse variance weighted,6,1.11 [0.95-1.29],0.192416044234242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.99 [0.94-1.05],0.843066908280227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.96 [0.82-1.13],0.625604200037174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,Inverse variance weighted,11,0.92 [0.82-1.02],0.103075990589817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,29,1.00 [0.97-1.03],0.899477118994658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,Inverse variance weighted,8,1.02 [0.93-1.11],0.655669924270193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,31,1.04 [0.99-1.10],0.126716898018123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,Inverse variance weighted,5,1.04 [0.82-1.31],0.74714888926931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,Inverse variance weighted,4,0.90 [0.78-1.03],0.120990500857686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.03 [0.89-1.20],0.650614993905186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,8,0.93 [0.84-1.02],0.107716908626024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,20,0.99 [0.92-1.07],0.811755180037458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,Inverse variance weighted,24,1.01 [0.97-1.05],0.558179585323833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,22,1.01 [0.95-1.06],0.840427966405983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.97-1.05],0.685912321858436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,1.08 [0.87-1.34],0.473360327975149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,Inverse variance weighted,35,1.02 [0.95-1.10],0.56090148187994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,4,1.09 [0.97-1.22],0.130639591433707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,Inverse variance weighted,28,1.00 [0.98-1.02],0.804566917157873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,24,1.05 [0.99-1.10],0.0915409620785438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,Inverse variance weighted,8,0.96 [0.85-1.08],0.498610568752466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,Inverse variance weighted,15,0.93 [0.84-1.03],0.156876688430693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,1.03 [0.81-1.31],0.834956182034045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,Inverse variance weighted,19,0.99 [0.95-1.04],0.808100904773823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,17,1.00 [0.95-1.06],0.976833588712637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.91-1.12],0.811398133850894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.01 [0.92-1.11],0.81097925825101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,0.96 [0.91-1.02],0.163487351732648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,Inverse variance weighted,23,0.95 [0.87-1.03],0.203626613169314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,Inverse variance weighted,11,0.99 [0.91-1.08],0.79551532188079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,23,1.01 [0.97-1.04],0.661327114255468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.97 [0.73-1.27],0.803643126229233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.86 [0.69-1.06],0.15300401563246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1.00 [0.85-1.16],0.952578071412374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.02 [0.97-1.06],0.490672441283754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,Inverse variance weighted,55,0.97 [0.94-1.01],0.114998071843196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,0.99 [0.95-1.04],0.760106857145685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,0.97 [0.70-1.37],0.881143562505635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,0.98 [0.93-1.02],0.296872924037044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,Wald ratio,1,0.92 [0.62-1.39],0.703044780388155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,Inverse variance weighted,46,1.01 [0.97-1.05],0.61065871079355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,1.03 [0.95-1.11],0.478413605468226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,Inverse variance weighted,19,0.96 [0.87-1.07],0.501195920573938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.01 [0.71-1.44],0.965217287236078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,Inverse variance weighted,2,1.59 [1.19-2.14],0.0018087193266562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,Inverse variance weighted,9,0.95 [0.85-1.07],0.411671563819903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,Inverse variance weighted,9,0.99 [0.91-1.09],0.894791861393785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,Inverse variance weighted,24,1.00 [0.97-1.04],0.901117894680367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,Inverse variance weighted,31,1.04 [0.97-1.10],0.286137921848902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,27,0.99 [0.95-1.03],0.704409595154479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,Inverse variance weighted,49,1.00 [0.97-1.04],0.866300512823519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,Inverse variance weighted,11,1.02 [0.96-1.09],0.522538757505931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,Inverse variance weighted,25,1.07 [1.02-1.11],0.0015354933116564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.08 [1.02-1.15],0.014035813969478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,Inverse variance weighted,29,1.02 [0.99-1.05],0.159338473841028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.09 [0.90-1.31],0.365603622135555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.06 [0.98-1.15],0.1435498218713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,Inverse variance weighted,42,1.02 [0.97-1.07],0.359119471971593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.00 [0.95-1.04],0.825451010937619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.27 [1.06-1.51],0.0083088423120668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,73,0.99 [0.97-1.02],0.479633134358073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,9,0.98 [0.87-1.09],0.669048160663708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.07 [0.97-1.17],0.168995462667298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,45,1.01 [0.98-1.05],0.44251573237179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,1.01 [0.97-1.04],0.763945971906932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.14 [1.02-1.27],0.024247832060699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.02 [0.99-1.04],0.13191115438043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,0.99 [0.95-1.04],0.679324053144189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,14,0.98 [0.91-1.05],0.516980402534198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,32,0.97 [0.92-1.03],0.329503954490032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.81 [0.53-1.23],0.317025493276862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.98-1.05],0.489659190821629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,1.09 [0.93-1.29],0.284267625073708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.00 [0.97-1.04],0.908571445146487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.00 [0.93-1.08],0.950383846434948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,34,0.98 [0.92-1.04],0.454925601312231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,Inverse variance weighted,9,1.00 [0.87-1.16],0.985257407217958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,0.99 [0.96-1.03],0.757820220284075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.01 [0.97-1.06],0.495977318550228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.15 [0.96-1.37],0.137924328870812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,Inverse variance weighted,7,1.08 [0.92-1.25],0.356596663801328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,Inverse variance weighted,11,0.92 [0.84-1.01],0.0688826777936709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,29,1.05 [0.98-1.12],0.147178050628018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.98 [0.88-1.10],0.751666550616108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,Inverse variance weighted,22,1.00 [0.97-1.04],0.850611288963737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,Inverse variance weighted,5,1.12 [0.82-1.52],0.48256331709486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.00 [0.96-1.03],0.830264545756456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.01 [0.92-1.10],0.86770023285133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,0.97 [0.90-1.04],0.366106945015559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,Inverse variance weighted,32,0.98 [0.91-1.05],0.568456762158368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,Inverse variance weighted,51,1.02 [0.99-1.06],0.197250365096943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,Inverse variance weighted,62,1.00 [0.97-1.03],0.959776036868382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,0.96 [0.88-1.06],0.468354916361421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,19,1.00 [0.91-1.11],0.973409276926236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.02 [0.91-1.15],0.738996980206285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,Inverse variance weighted,25,1.01 [0.96-1.06],0.804649699846709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,Inverse variance weighted,33,0.98 [0.94-1.03],0.379435923032172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,6,0.94 [0.85-1.04],0.230875905689033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,Inverse variance weighted,13,1.02 [0.96-1.10],0.506395318977731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,Inverse variance weighted,23,1.04 [0.98-1.11],0.178586314208181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,Inverse variance weighted,31,0.97 [0.92-1.03],0.342929668703307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.01 [0.85-1.20],0.938473631166645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.97 [0.89-1.05],0.435820109162984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,Inverse variance weighted,45,1.04 [0.99-1.08],0.150434884742479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,0.99 [0.96-1.02],0.581348226511387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,30,1.00 [0.93-1.07],0.995034194641103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.97 [0.83-1.14],0.731491905787584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,0.97 [0.92-1.03],0.2982752741553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,Inverse variance weighted,15,1.05 [0.93-1.17],0.434227592121144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,1.02 [0.89-1.17],0.779986735165324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,0.99 [0.94-1.04],0.679264367270747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,1.00 [0.90-1.12],0.98683514309839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.35 [0.70-2.60],0.368742648820698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,Inverse variance weighted,16,0.96 [0.90-1.01],0.13056781205573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,Inverse variance weighted,4,1.13 [0.88-1.45],0.333935789336787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,29,1.02 [0.94-1.10],0.643244138739326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,Inverse variance weighted,35,1.02 [0.98-1.07],0.355989802497861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,0.99 [0.93-1.05],0.713406917198584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,Inverse variance weighted,4,1.10 [0.77-1.58],0.588188849353619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.96 [0.90-1.02],0.172910386549572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,0.82 [0.51-1.31],0.400978143941019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,0.94 [0.83-1.07],0.371852571234773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.93 [0.83-1.04],0.189725202575734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.99 [0.85-1.16],0.93333132174281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.03 [0.96-1.11],0.356960783801042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.02 [0.99-1.05],0.144662303721101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.98 [0.71-1.36],0.920685624203614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.07 [0.67-1.69],0.78174036284882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,34,0.99 [0.94-1.03],0.594052470913848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,Inverse variance weighted,18,0.96 [0.90-1.03],0.247736486802726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,Inverse variance weighted,9,0.95 [0.84-1.07],0.404999194745461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.92 [0.73-1.14],0.442666568421808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,Inverse variance weighted,14,1.00 [0.94-1.07],0.957323320152488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.02 [0.98-1.05],0.35008825715643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,42,1.01 [0.97-1.05],0.550185454081328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,Inverse variance weighted,15,0.98 [0.91-1.05],0.512971292307737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,0.99 [0.97-1.01],0.187096126598182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,Inverse variance weighted,18,1.02 [0.93-1.12],0.700171694474663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,27,0.98 [0.90-1.07],0.635309680762686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.00 [0.95-1.04],0.847181977751468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,Inverse variance weighted,3,0.85 [0.51-1.41],0.534950874635755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,0.99 [0.89-1.10],0.856033169013829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.02 [0.95-1.09],0.60762316275513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,Inverse variance weighted,8,0.98 [0.86-1.12],0.752925904768702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.96 [0.81-1.15],0.67741290413957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,Inverse variance weighted,19,0.95 [0.83-1.07],0.376104717097286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,Inverse variance weighted,21,0.97 [0.88-1.06],0.486549747084158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,0.98 [0.94-1.03],0.414246638094071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,Inverse variance weighted,32,0.99 [0.96-1.03],0.703340210968053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.00 [0.96-1.05],0.863824984711531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,Inverse variance weighted,14,1.07 [0.97-1.19],0.170579403733591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,0.92 [0.70-1.21],0.561235034730345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.99 [0.78-1.24],0.914549618573282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,40,1.00 [0.96-1.05],0.867101708579676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,1.10 [1.03-1.17],0.005843635979125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,Inverse variance weighted,36,1.03 [0.99-1.08],0.131499756330192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,Inverse variance weighted,2,1.10 [0.91-1.32],0.320988951773772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,12,1.02 [0.98-1.07],0.380952398698321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,Inverse variance weighted,8,0.96 [0.91-1.02],0.198403145147361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,Inverse variance weighted,20,0.99 [0.95-1.03],0.616019065214102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.04 [0.87-1.23],0.674311519222737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,Inverse variance weighted,8,1.13 [0.97-1.31],0.118877202410634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,Inverse variance weighted,12,1.08 [0.95-1.22],0.255386434301629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.00 [0.92-1.09],0.989961984324509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,0.98 [0.96-1.01],0.174238102329062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,50,0.97 [0.94-1.01],0.113824235740014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.25 [1.06-1.48],0.009496162681451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.01 [0.92-1.10],0.849914429750223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.98-1.05],0.448497019579027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.00 [0.94-1.05],0.894683438441818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,Inverse variance weighted,31,0.94 [0.88-1.00],0.0547639737335292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,Inverse variance weighted,24,1.00 [0.94-1.05],0.868316517977015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,Inverse variance weighted,8,1.10 [1.00-1.21],0.0455889301999894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,1.02 [0.99-1.06],0.209257812852905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,0.99 [0.96-1.03],0.776024651376162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,24,1.06 [1.01-1.11],0.0247293645606975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,58,1.07 [1.02-1.11],0.0017571247580669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.99 [0.90-1.10],0.919050449601685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.06 [0.86-1.31],0.562600077831453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,20,1.01 [0.93-1.09],0.882651460744361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.88 [0.78-1.00],0.0496860129970448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,Inverse variance weighted,19,0.99 [0.89-1.10],0.839631923209726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,34,0.97 [0.94-1.01],0.156987089081345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,Inverse variance weighted,34,0.99 [0.95-1.03],0.666335779959389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,25,1.02 [0.97-1.06],0.468918351224719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,38,1.00 [0.96-1.05],0.835655111763153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,Inverse variance weighted,54,1.06 [1.00-1.11],0.0354048464536237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,Inverse variance weighted,26,1.05 [0.96-1.15],0.287042775892885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,Inverse variance weighted,35,0.99 [0.95-1.04],0.714569595971128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,9,1.08 [0.99-1.17],0.0691349036360366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,Inverse variance weighted,49,1.03 [0.97-1.09],0.299919068379829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,1.04 [0.98-1.11],0.199495153002253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,0.99 [0.92-1.06],0.732685053411423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,40,1.05 [1.00-1.11],0.0570380558644238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.06 [0.95-1.18],0.326954248273272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,34,1.00 [0.95-1.05],0.903211308955798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.06 [0.94-1.19],0.376329592578075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,Inverse variance weighted,7,1.05 [0.98-1.12],0.132512146507469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,Inverse variance weighted,6,1.22 [0.97-1.53],0.0936876374784554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.00 [0.92-1.09],0.969845151607289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,Inverse variance weighted,7,0.98 [0.88-1.10],0.784551535225689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.04 [0.89-1.20],0.646524606515513
